Neogenomics, Inc. · NASDAQ:NEO
Vanguard Capital Management LLC reported a 5.09% stake in Neogenomics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 30, 2026
Vanguard Capital Management LLC reported a 5.09% stake in Neogenomics, Inc., 6,610,272 shares, as a passive investor on Mar 31, 2026. Filed Apr 30, 2026 (Schedule 13G).
- Stake
- 5.09%
- Shares
- 6,610,272
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.09% | 6,610,272 |